Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
Farmers Insurance
Baxter
Accenture
Dow
Fish and Richardson
Federal Trade Commission
Citi
Covington

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,811,120

« Back to Dashboard

Summary for Patent: 5,811,120
Title: Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
Abstract:This invention provides solid orally administerable pharmaceutical formulations comprising raloxifene hydrochloride, a surfactant being sorbitan fatty acid ester or a polyoxyethylene sorbitan fatty acid ester, polyvinylpyrrolidone, and a water soluble diluent which is polyol or sugar.
Inventor(s): Gibson; Lowell L. (Greenwood, IN), Hartauer; Kerry J. (Indianapolis, IN), Stowers; Julian L. (Indianapolis, IN), Sweetana; Stephanie A. (Bloomington, IN), Thakkar; Arvind L. (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:08/824,590
Patent Claim Types:
see list of patent claims
Formulation; Compound; Composition; Dosage form;

Drugs Protected by US Patent 5,811,120

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,811,120

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 211910 ➤ Try a Free Trial
Australia 1354895 ➤ Try a Free Trial
Australia 684882 ➤ Try a Free Trial
Brazil 9500758 ➤ Try a Free Trial
Canada 2143263 ➤ Try a Free Trial
China 1098684 ➤ Try a Free Trial
China 1112420 ➤ Try a Free Trial
Colombia 4340620 ➤ Try a Free Trial
Czech Republic 286119 ➤ Try a Free Trial
Czech Republic 9500499 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Dow
McKesson
McKinsey
Harvard Business School
Healthtrust
Fuji
Teva
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot